Jonathan Leff

Insider Reports History

Entity
Individual
Location
C/O Deerfield Management Company, L.P, 780 Third Avenue, 37 Th Floor, New York, NY
Signature
/s/ Jonathan Leff
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Leff:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BiomX Inc. Director Common Stock Options - Right to Buy 264K Jul 11, 2024 Direct
Larimar Therapeutics, Inc. Director Stock Option (Right to Buy) 19K May 29, 2024 Direct

Insider Reports Filed by Jonathan Leff

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PHGE BiomX Inc. Jul 11, 2024 1 $0 4 Jul 15, 2024 Director
LRMR Larimar Therapeutics, Inc. May 29, 2024 1 $0 4 May 31, 2024 Director
PHGE BiomX Inc. Mar 15, 2024 0 $0 3 Mar 21, 2024 Director
LRMR Larimar Therapeutics, Inc. May 9, 2023 1 $0 4 May 11, 2023 Director
SPRY ARS Pharmaceuticals, Inc. Nov 8, 2022 0 $0 3 Nov 10, 2022 Director
LRMR Larimar Therapeutics, Inc. May 10, 2022 1 $0 4 May 12, 2022 Director
LRMR Larimar Therapeutics, Inc. May 12, 2021 1 $0 4 May 17, 2021 Director